1.Mitochondria derived from human embryonic stem cell-derived mesenchymal stem cells alleviate the inflammatory response in human gingival fibroblasts.
Bicong GAO ; Chenlu SHEN ; Kejia LV ; Xuehui LI ; Yongting ZHANG ; Fan SHI ; Hongyan DIAO ; Hua YAO
Journal of Zhejiang University. Science. B 2025;26(8):778-788
Periodontitis is a common oral disease caused by bacteria coupled with an excessive host immune response. Stem cell therapy can be a promising treatment strategy for periodontitis, but the relevant mechanism is complicated. This study aimed to explore the therapeutic potential of mitochondria from human embryonic stem cell-derived mesenchymal stem cells (hESC-MSCs) for the treatment of periodontitis. The gingival tissues of periodontitis patients are characterized by abnormal mitochondrial structure. Human gingival fibroblasts (HGFs) were exposed to 5 μg/mL lipopolysaccharide (LPS) for 24 h to establish a cell injury model. When treated with hESC-MSCs or mitochondria derived from hESC-MSCs, HGFs showed reduced expression of inflammatory genes, increased adenosine triphosphate (ATP) level, decreased reactive oxygen species (ROS) production, and enhanced mitochondrial function compared to the control. The average efficiency of isolated mitochondrial transfer by hESC-MSCs was determined to be 8.93%. Besides, a therapy of local mitochondrial injection in mice with LPS-induced periodontitis showed a reduction in inflammatory gene expression, as well as an increase in both the mitochondrial number and the aspect ratio in gingival tissues. In conclusion, our results indicate that mitochondria derived from hESC-MSCs can reduce the inflammatory response and improve mitochondrial function in HGFs, suggesting that the transfer of mitochondria between hESC-MSCs and HGFs serves as a potential mechanism underlying the therapeutic effect of stem cells.
Humans
;
Gingiva/cytology*
;
Fibroblasts/metabolism*
;
Mitochondria/physiology*
;
Mesenchymal Stem Cells/cytology*
;
Animals
;
Periodontitis/therapy*
;
Mice
;
Reactive Oxygen Species/metabolism*
;
Inflammation
;
Lipopolysaccharides
;
Human Embryonic Stem Cells/cytology*
;
Cells, Cultured
;
Adenosine Triphosphate/metabolism*
;
Male
2.Adhesive and injectable hydrogel microspheres for NRF2-mediated periodontal bone regeneration.
Yu WANG ; Shanshan JIN ; Yaru GUO ; Yilong LU ; Xuliang DENG
International Journal of Oral Science 2025;17(1):7-7
Regenerating periodontal bone defect surrounding periodontal tissue is crucial for orthodontic or dental implant treatment. The declined osteogenic ability of periodontal ligament stem cells (PDLSCs) induced by inflammation stimulus contributes to reduced capacity to regenerate periodontal bone, which brings about a huge challenge for treating periodontitis. Here, inspired by the adhesive property of mussels, we have created adhesive and mineralized hydrogel microspheres loaded with traditional compound cordycepin (MMS-CY). MMS-CY could adhere to the surface of alveolar bone, then promote the migration capacity of PDLSCs and thus recruit them to inflammatory periodontal tissues. Furthermore, MMS-CY rescued the impaired osteogenesis and ligament-forming capacity of PDLSCs, which were suppressed by the inflammation stimulus. Moreover, MMS-CY also displayed the excellent inhibitory effect on the osteoclastic activity. Mechanistically, MMS-CY inhibited the premature senescence induced by the inflammation stimulus through the nuclear factor erythroid 2-related factor (NRF2) pathway and reducing the DNA injury. Utilizing in vivo rat periodontitis model, MMS-CY was demonstrated to enhance the periodontal bone regeneration by improving osteogenesis and inhibiting the osteoclastic activity. Altogether, our study indicated that the multi-pronged approach is promising to promote the periodontal bone regeneration in periodontitis condition by reducing the inflammation-induced stem cell senescence and maintaining bone homeostasis.
Animals
;
Bone Regeneration/drug effects*
;
Rats
;
Periodontal Ligament/cytology*
;
Microspheres
;
NF-E2-Related Factor 2
;
Hydrogels
;
Periodontitis/therapy*
;
Osteogenesis/drug effects*
;
Disease Models, Animal
;
Stem Cells
;
Male
;
Rats, Sprague-Dawley
;
Humans
3.Treatment strategies for immature permanent teeth under general anesthesia.
Ying LI ; Xiaoyu FENG ; Ruizhi JIA ; Yong WANG ; Jiajian SHANG
West China Journal of Stomatology 2025;43(4):462-468
Immature permanent teeth refer to those that have erupted but have not yet formed and matured in terms of shape and structure. The characteristics of their disease onset and treatment methods are different from those of ordinary permanent teeth. Children with special healthcare needs often lack the capacity to cooperate during routine dental procedures, making treatment under general anesthesia (GA) the preferred option. With social advancements, the demand for pediatric dental GA has considerably increased. This study discuss the treatment strategies for immature permanent teeth under GA, including diagnosis, therapeutic principles, key considerations, and clinical approaches for dental caries, pulpitis periapical periodontitis, etc.
Child
;
Humans
;
Anesthesia, General
;
Dental Caries/diagnosis*
;
Dentition, Permanent
;
Periapical Periodontitis/therapy*
;
Pulpitis/therapy*
4.Mechanism of Eclipta prostrata L-Ligustrum lucidum Ait in the treatment of periodontitis.
Mengru GUO ; Tianyi ZHANG ; Jingwen HUANG ; Xinyue HUANG ; Yi ZHENG ; Li ZHANG
West China Journal of Stomatology 2025;43(5):696-710
OBJECTIVES:
This study aimed to explore the potential target and molecular mechanism of Eclipta prostrata L-Ligustrum Lucidum Ait (EPL-LLA) in the treatment of periodontitis by using network pharmacology and molecular docking technology, and to explore its biocompatibility, regulatory effects on inflammatory factors, and antioxidant acti-vity through in vitro experiments.
METHODS:
The active components and potential targets of EPL-LLA were screened and predicted through a variety of databases, and the intersection of EPL-LLA and periodontitis targets was selected. The protein interaction network (PPI) was analyzed by the string platform. The Metascape database was used for gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis. The active ingredients from the top 6 degrees were docked with the core targets, and the results of binding energy were visualized. An in vitro cell model was established to evaluate the biocompatibility, modulation of inflammatory factors, and antioxidative effects of EPL-LLA through cell counting kit-8 (CCK-8), quantitative real-time polymerase chain reaction (qRT-PCR) and 2',7'-Dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescent probe assays.
RESULTS:
Screening revealed 13 active components in EPL corresponding to 220 potential targets, 10 active components in LLA corresponding to 283 potential targets, and 1 643 periodontitis-related targets, with 91 shared targets among the three. GO analysis of the shared targets yielded 5 271 entries, while KEGG enrichment analysis indicated involvement in 253 signaling pathways. Molecular docking confirmed stable binding between the top 6 active components and core targets. CCK-8 assays demonstrated good biocompatibility of EPL-LLA at concentrations 0.02 mg/mL (P<0.05). qRT-PCR showed that EPL-LLA reduced the mRNA expression of pro-inflammatory factors in macrophages stimulated by Porphyromonas gingivalis lipopolysaccharide while upregulating anti-inflammatory factor mRNA expression (P<0.05). DCFH-DA fluorescence probe assays confirmed the reactive oxygen species (ROS)-scavenging capacity of EPL-LLA (P<0.05).
CONCLUSIONS
EPL-LLA may treat periodontitis through multi-component, multi-target, and multi-pathway mechanisms, providing a theoretical basis for further research on its therapeutic potential.
Periodontitis/drug therapy*
;
Molecular Docking Simulation
;
Eclipta/chemistry*
;
Humans
;
Protein Interaction Maps
;
Ligustrum/chemistry*
;
Antioxidants/pharmacology*
;
Drugs, Chinese Herbal/therapeutic use*
;
Network Pharmacology
5.Clinical diagnosis and treatment of furcation involvement.
Chinese Journal of Stomatology 2023;58(6):609-614
Furcation involvement (FI) is the lesion and destruction of periodontium that spread to the root furcation of multi-root teeth, where periodontal pockets, loss of periodontal attachment and resorption of alveolar bone are formed. Furcation involvement is a common concomitant lesion of periodontitis. The severity of furcation involvement can directly affect the prognosis of periodontitis. However, the specificity of the anatomical structure of the root furcation greatly increases the difficulty of treatment. Therefore, early detection and treatment of furcation involvement is crucial for the prevention and control of periodontitis. This paper briefly describes the pathogenesis of furcation involvement and discusses the diagnosis, classification and treatment of this disease, which is helpful to improve the clinical diagnosis and treatment of furcation involvement.
Humans
;
Molar
;
Furcation Defects/therapy*
;
Periodontitis/complications*
;
Periodontal Pocket
;
Prognosis
6.Diagnosis and treatment strategy of periodontitis with diabetes.
Xue Xue SHI ; Jin Hua GAO ; Xiu Yun REN
Chinese Journal of Stomatology 2023;58(6):615-620
The number of diabetic patients visiting stomatology for periodontal disease is increasing, and the symptoms are relatively severe, and often complications increase the complexity of periodontal treatment. This article briefly describes the research progress and clinical manifestations of the epidemiology and related pathological mechanisms of periodontitis with diabetes, focusing on the treatment and providing reference for stomatologists in the clinical diagnosis and treatment of patients with diabetic periodontitis.
Humans
;
Periodontitis/therapy*
;
Diabetes Mellitus/therapy*
;
Periodontal Diseases
;
Dental Care
;
Diabetes Mellitus, Type 2
;
Diabetes Complications/complications*
7.Study on the mechanism of curcumin in the treatment of periodontitis through network pharmacology and mole-cular docking.
Jingmei YANG ; Ziliang ZHOU ; Yafei WU ; Min NIE
West China Journal of Stomatology 2023;41(2):157-164
OBJECTIVES:
This study aims to explore the therapeutic targets of curcumin in periodontitis through network pharmacology and molecular docking technology.
METHODS:
Targets of curcumin and periodontitis were predicted by different databases, and the protein-protein interaction (PPI) network constructed by String revealed the interaction between curcumin and periodontitis. The key target genes were screened for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Molecular docking was performed to analyze the binding potential of curcumin to periodontitis.
RESULTS:
A total of 672 periodontitis-related disease targets and 107 curcumin-acting targets were obtained from the databases, and 20 key targets were screened. The GO and KEGG analyses of the 20 targets showed that curcumin might play a therapeutic role through the hypoxia-inducible factor (HIF)-1 and parathyroid hormone (PTH) signaling pathways. Molecular docking analysis showed that curcumin had good binding potential with multiple targets.
CONCLUSIONS
The potential key targets and molecular mechanisms of curcumin in treating periodontitis provide a theoretical basis for new drug development and clinical applications.
Humans
;
Network Pharmacology
;
Curcumin/therapeutic use*
;
Molecular Docking Simulation
;
Periodontitis/drug therapy*
;
Drugs, Chinese Herbal
;
Medicine, Chinese Traditional
8.Root canal treatment of type Ⅱ and ⅢA double dens invaginatus in maxillary lateral incisor: a case report.
West China Journal of Stomatology 2023;41(2):232-236
Dens invaginatus is a rare developmental anomaly of the teeth that is caused by the infolding of enamel organs or the penetration of their proliferations into dental papillae before calcification has occurred. The presence of double dens invaginatus is extremely rare. This paper describes the use of cone beam computed tomography in the evaluation of a maxillary lateral incisor with double dens invaginatus and periapical periodontitis. The tooth was treated through microscopic root canal therapy. The tooth was free of clinical symptoms, and the periradicular lesion narrowed during the follow-up period of 1 year.
Humans
;
Dental Pulp Cavity/abnormalities*
;
Dens in Dente/pathology*
;
Incisor/pathology*
;
Root Canal Therapy
;
Periapical Periodontitis/pathology*
9.Diagnosis and treatment of apical cyst of deciduous teeth with infection: a case report.
Yue ZHANG ; Xiaowen LIU ; Ran YANG
West China Journal of Stomatology 2023;41(3):356-360
There is a high incidence of chronic periapical periodontitis of deciduous teeth, however, there is a low incidence of the apical cyst. This paper reports a 7-year-old child with deciduous periodontitis caused by chronic periapical periodontitis of deciduous teeth. Through literature review, the etiology, imaging characteristics, diagnosis, differential diagnosis, and treatment methods were discussed to provide the basis for clinical diagnosis and treatment.
Child
;
Humans
;
Cysts
;
Diagnosis, Differential
;
Periapical Periodontitis/therapy*
;
Tooth, Deciduous
10.CD301b+ macrophage: the new booster for activating bone regeneration in periodontitis treatment.
Can WANG ; Qin ZHAO ; Chen CHEN ; Jiaojiao LI ; Jing ZHANG ; Shuyuan QU ; Hua TANG ; Hao ZENG ; Yufeng ZHANG
International Journal of Oral Science 2023;15(1):19-19
Periodontal bone regeneration is a major challenge in the treatment of periodontitis. Currently the main obstacle is the difficulty of restoring the regenerative vitality of periodontal osteoblast lineages suppressed by inflammation, via conventional treatment. CD301b+ macrophages were recently identified as a subpopulation that is characteristic of a regenerative environment, but their role in periodontal bone repair has not been reported. The current study indicates that CD301b+ macrophages may be a constituent component of periodontal bone repair, and that they are devoted to bone formation in the resolving phase of periodontitis. Transcriptome sequencing suggested that CD301b+ macrophages could positively regulate osteogenesis-related processes. In vitro, CD301b+ macrophages could be induced by interleukin 4 (IL-4) unless proinflammatory cytokines such as interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) were present. Mechanistically, CD301b+ macrophages promoted osteoblast differentiation via insulin-like growth factor 1 (IGF-1)/thymoma viral proto-oncogene 1 (Akt)/mammalian target of rapamycin (mTOR) signaling. An osteogenic inducible nano-capsule (OINC) consisting of a gold nanocage loaded with IL-4 as the "core" and mouse neutrophil membrane as the "shell" was designed. When injected into periodontal tissue, OINCs first absorbed proinflammatory cytokines in inflamed periodontal tissue, then released IL-4 controlled by far-red irradiation. These events collectively promoted CD301b+ macrophage enrichment, which further boosted periodontal bone regeneration. The current study highlights the osteoinductive role of CD301b+ macrophages, and suggests a CD301b+ macrophage-targeted induction strategy based on biomimetic nano-capsules for improved therapeutic efficacy, which may also provide a potential therapeutic target and strategy for other inflammatory bone diseases.
Animals
;
Mice
;
Bone Regeneration
;
Cytokines/metabolism*
;
Interleukin-4/therapeutic use*
;
Macrophages/physiology*
;
Mammals
;
Osteogenesis
;
Periodontitis/drug therapy*

Result Analysis
Print
Save
E-mail